Feature Channels:

Infectious Diseases

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

UCLA's Dr. Jeffrey Klausner Is Available for Interviews About Mumps Outbreak in Los Angeles County

Dr.JeffreyKlausner.jpg

Medicine

Channels:

West Nile Virus, zika virus, National Institute Of Allergy And Infectious Diseases, National Institutes Of Health (NIH), central nervous system, Brain Infections, Margo Brinton, Brain Cells, Organoids

Researchers Receive $7.7 Million Grant to Study West Nile and Zika Viruses

brintonp-300x300.jpg

A Georgia State University researcher, in collaboration with researchers at the University of Pennsylvania and Florida State University, has received a five-year, $7.7 million federal grant to study the consequences of West Nile and Zika virus infections on the human central nervous system.

Medicine

Channels:

Sexually Transmitted Disease, Sexually Transmitted Infections, Gonorrhea, Chlamydia

STD Treatment for Two?

In some states, patients who test positive for chlamydia or gonorrhea leave the clinic with not only a prescription for themselves, but also one for their sexual partner — who was not seen by a doctor.

Medicine

Channels:

SLAC National Accelerator Laboratory, Lassa virus, SSRL, Stanford Synchrotron Radiation Lightsource, Science, Biological Science, lightsource, X-ray Crystallogaphy

SLAC X-Ray Beam Helps Uncover Blueprint for Lassa Virus Vaccine

blueprint.jpeg

A team of scientists from The Scripps Research Institute (TSRI) has solved the structure of the viral machinery that Lassa virus uses to enter human cells. X-ray beams from the Stanford Synchrotron Radiation Lightsource (SSRL) at the Department of Energy's SLAC National Accelerator Laboratory gave the team the final piece in a puzzle they sought to solve for over 10 years.

Medicine

Channels:

flu, Influenza, Modeling & Simulation

Study Provides Guidelines on How to Prioritize Vaccination During Flu Season

IMG_8280.JPG

After high-risk individuals, immunizing children and the elderly will have the greatest overall benefit when there are limited vaccine resources, Virginia Tech researchers found.

Medicine

Channels:

Lassa, Ebola, Virus, Vaccine, West Africa, Imaging, X-ray Crystallogaphy, Structural Biology, San Diego, Tulane

Perseverance Pays Off in Fight Against Deadly Lassa Virus

surface_side.jpg

This story starts with a young graduate student in San Diego and leads all the way to Sierra Leone, to a unique hospital where Lassa fever victims arrive by the thousands every year.

Medicine

Science

Channels:

Lassa virus, Lassa Fever, science (journal), Arenaviruses, infectious and emerging disease, Tulane University

Research Team Unravels Elusive Structure of Lassa Virus, Revealing Vaccine Target

BGarry_JRobinson_4850-hpr.jpg

A team of scientists have for the first time mapped the molecular structure of an elusive surface protein on the Lassa virus that allows the pathogen to infect human cells.

Medicine

Channels:

AIDS, HIV, Homelessness, supportive housing, CD4 count, Viral Load, viral suppression, PLWHA

Supportive Housing Improves Health of Formerly Homeless People with HIV/AIDS

Ask Elizabeth Bowen about the intersection of homelessness and HIV/AIDS in the United States and she’ll respond without hesitation, “Housing equals health.”

Science

Channels:

Cryptosporidiosis, Cryptosporidium, Disease, Diarrhea, Drug Discovery, Child Mortality

UGA Researchers Report Milestone in Global Fight Against a Major Cause of Diarrheal Disease

Striepen_Boris.jpg

Infectious disease scientists from research institutions including the University of Georgia have reported the discovery and early validation of a drug that shows promise for treating cryptosporidiosis, a diarrheal disease that is a major cause of child mortality and for which there is no vaccine or effective treatment.

Medicine

Channels:

Orphan disease, rare disease

Penn Orphan Disease Center to Develop Rare Disease Patient Registries

The Penn Orphan Disease Center will collaborate with Pulse Infoframe Inc., a medical informatics company, to develop rare disease patient registries aimed at enabling international collaboration to better understand these diseases, as well as accelerate and improve clinical studies to develop new therapies.







Chat now!